Corcept Therapeutics Incorporated provided earnings guidance for the full year of 2022. For the period, the company expects revenue to be in the range of $400 million and $430 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.52 USD | -1.15% | -2.03% | -15.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.27% | 2.9B | |
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B |
- Stock Market
- Equities
- CORT Stock
- News Corcept Therapeutics Incorporated
- Corcept Therapeutics Incorporated Provides Earnings Guidance for the Full Year of 2022